home / stock / gild / gild short
Short Information | Gilead Sciences Inc. (NASDAQ:GILD)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 11,926,239 |
Total Actual Volume | 137,022,751 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 596,312 |
Average Short Percentage | 8.96% |
Is there a GILD Short Squeeze or Breakout about to happen?
See the GILD Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-25-2024 | $67.47 | $65.27 | $67.9 | $65.09 | 15,171,959 | 1,302,756 | 8.59% |
04-24-2024 | $66.58 | $67.08 | $67.185 | $66.365 | 8,271,889 | 258,351 | 3.12% |
04-23-2024 | $67.09 | $67.03 | $67.68 | $66.995 | 5,222,191 | 415,191 | 7.95% |
04-22-2024 | $66.93 | $66.95 | $67.565 | $66.74 | 5,622,367 | 414,037 | 7.36% |
04-19-2024 | $66.25 | $66.76 | $66.83 | $66.16 | 10,657,002 | 762,562 | 7.16% |
04-18-2024 | $67.01 | $66.16 | $67.02 | $65.9 | 6,442,224 | 658,942 | 10.23% |
04-17-2024 | $67.35 | $66.93 | $67.55 | $66.89 | 5,287,730 | 778,656 | 14.73% |
04-16-2024 | $67.8 | $67.31 | $67.89 | $67.185 | 4,975,048 | 594,408 | 11.95% |
04-15-2024 | $68.27 | $67.75 | $68.455 | $67.7 | 7,717,826 | 675,531 | 8.75% |
04-12-2024 | $68.52 | $68.07 | $68.62 | $67.62 | 5,691,760 | 715,390 | 12.57% |
04-11-2024 | $68.46 | $68.65 | $69.025 | $68.305 | 6,071,511 | 593,044 | 9.77% |
04-10-2024 | $69.76 | $68.12 | $69.76 | $68.0649 | 7,983,148 | 613,452 | 7.68% |
04-09-2024 | $69.16 | $69.94 | $69.95 | $69.11 | 5,928,204 | 434,740 | 7.33% |
04-08-2024 | $69.05 | $69.42 | $69.55 | $69.05 | 4,589,099 | 404,753 | 8.82% |
04-05-2024 | $69.69 | $69.58 | $70.0098 | $68.54 | 6,599,542 | 460,160 | 6.97% |
04-04-2024 | $71.24 | $69.55 | $71.39 | $69.395 | 7,341,192 | 718,891 | 9.79% |
04-03-2024 | $72 | $70.89 | $72.17 | $70.7 | 5,145,312 | 677,801 | 13.17% |
04-02-2024 | $72.82 | $72.09 | $72.85 | $71.9 | 6,138,986 | 398,569 | 6.49% |
04-01-2024 | $73.22 | $72.88 | $73.22 | $72.38 | 3,796,058 | 292,003 | 7.69% |
03-28-2024 | $73.25 | $73.25 | $73.87 | $73.2 | 8,369,703 | 757,002 | 9.04% |
News, Short Squeeze, Breakout and More Instantly...
– Additional Data in Pregnant Adults Who Are Virologically Suppressed Reinforce Safety and Tolerability Profile of Biktarvy in Broad Range of People With HIV – – Perinatal Guidelines Recognize Biktarvy as Alternative Regimen for Use During Pregnancy an...
2024-04-25 21:45:15 ET Image source: The Motley Fool. Gilead Sciences (NASDAQ: GILD) Q1 2024 Earnings Call Apr 25, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
Product Sales Excluding Veklury Increased 6% Year-Over-Year to $6.1 billion Biktarvy Sales Increased 10% Year-Over-Year to $2.9 billion Oncology Sales Increased 18% Year-Over-Year to $789 million Closed CymaBay Acquisition Resulting in $3.9 billion Acquired IPR&D Charg...